Co-Authors
This is a "connection" page, showing publications co-authored by Pierpaolo Di Micco and Giuseppe Cardillo.
Connection Strength
1.375
-
Clinical Differences between COVID-19 and a COVID-Like Syndrome. J Clin Med. 2021 Jun 07; 10(11).
Score: 0.237
-
Antithrombotic and Anti-Inflammatory Effects of Fondaparinux and Enoxaparin in Hospitalized COVID-19 Patients: The FONDENOXAVID Study. J Blood Med. 2021; 12:69-75.
Score: 0.232
-
Prognostic Value of Fibrinogen among COVID-19 Patients Admitted to an Emergency Department: An Italian Cohort Study. J Clin Med. 2020 Dec 21; 9(12).
Score: 0.230
-
Thromboprofilaxys With Fondaparinux vs. Enoxaparin in Hospitalized COVID-19 Patients: A Multicenter Italian Observational Study. Front Med (Lausanne). 2020; 7:569567.
Score: 0.229
-
Fondaparinux Use in Patients With COVID-19: A Preliminary Multicenter Real-World Experience. J Cardiovasc Pharmacol. 2020 10; 76(4):369-371.
Score: 0.226
-
Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort. J Clin Med. 2020 May 07; 9(5).
Score: 0.220